Association of rs16917496 polymorphism at the miR-502 binding site in the SET8 3'UTR with the risk of Prostate Cancer and benign prostatic hyperplasia
Novelty in Biomedicine. 2018; 6 (2): 74-78
Dans Anglais
| IMEMR
| ID: emr-198496
ABSTRACT
Background:
MicroRNAs [miRNAs] can bind to the 3'-untranslated regions [UTRs] of messenger RNAs, where they interfere with translation and thereby regulate cell differentiation, apoptosis, and tumorigenesis. Genetic polymorphisms in the 3'-UTRs targeted by miRNAs alter the strength of miRNA binding in a manner that affects the behavior of individual miRNAs. The histone methyltransferase SET8 has been reported to be a regulator of Tumor Protein 53 [TP53] methylation, a tumor suppressor gene, and regulate genomic stability. Furthermore, an association between the TP53 and Prostate Cancer has been reported in several studies. The present study aimed to evaluate whether [rs16917496] polymorphism at the miR-502 binding site in the 3' untranslated region of the histone methyltransferase SET8 is associated with the expression of this gene in Benign Prostatic Hyperplasia [BPH] and prostate cancer [PCa] patients
Recherche sur Google
Indice:
Méditerranée orientale
langue:
Anglais
Texte intégral:
Novelty Biomed.
Année:
2018
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS